Method and system for characterization and mapping of tissue lesions
The present invention provides a method and an apparatus for the in vivo, non-invasive, early detection of alterations and mapping of the grade of these alterations, caused in the biochemical and/or in the functional characteristics of epithelial tissues during the development of tissue atypias, dysplasias, neoplasias and cancers. The method is based, at least in part, on the simultaneous measurement of the spatial, temporal and spectral alterations in the characteristics of the light that is re-emitted from the tissue under examination, as a result of a combined tissue excitation with light and special chemical agents. The topical or systematic administration of these agents result in an evanescent contrast enhancement between normal and abnormal areas of tissue. The apparatus enables the capturing of temporally successive imaging in one or more spectral bands simultaneously. Based on the measured data, the characteristic curves that express the agent-tissue interaction kinetics, as well as numerical parameters derived from these data, are determined in any spatial point of the examined area. Mapping and characterization of the lesion, are based on these parameters.
1. A method for monitoring the effects of a pathology differentiating agent on a sample, the method comprising the steps of:
(a) exposing the sample to linearly polarized light;
(b) applying a pathology differentiating agent on the sample;
(c) initiating a measurement period relative to said applying step, wherein the application of the pathology differentiating agent to the sample and the initiation of the measurement period are synchronized;
(d) capturing a plurality of successive images of said sample during said measurement period;
(e) measuring an optical signal observed from said sample within said measurement period;
wherein a relative motion between the sample and an optical head is substantially eliminated in order to substantially align the spatial points of the sample and the optical head.
2. The method of claim 1 , wherein
said applying step comprises applying said pathology differentiating agent as a mist in a predefined pattern on said tissue.
3. The method of claim 2 , wherein
said mist is a controlled volume.
4. The method of claim 2 , wherein
said applying occurs at a controlled rate.